How Bex Works
Bex Administration
Bex Safety
100

What does Bexlutry bind to which are found in many GEP NET cells and delivers targeted radiation to?

Somatostatin receptors (SSTRs)

100

T or F

Decrease the dose of Amino Acid solution if the dose of Bexlutry is reduced

False

100

What two drugs interact with Bexlutry?

Somatostatin Analogs

Glucocorticoids

200

What guidelines include Lutetium 177 Dotatate as 1st line therapy with well differentiated GEP NETs?

NCCN Guidelines

200

Name 3 of the 5 conditions why a Bexlutry dose should be modified?

Hematologic

Renal

Hepatic

Hypersensitivity

Other adverse reactions

200

Name two of the Grade 3-4 adverse reactions?

lymphopenia, increased GGT, vomiting, nausea, increased AST, increased ALT, hyperglycemia and hypokalemia.

300

What is recommended as the first step to administer prior to the Bexlutry infusion?

Anti-Nausea Medication (antiemetics)

300

Daily DOUBLE

What is the half-life of Bexlutry?

6.6 days 

Bonus 100 points - How long would it need to be stored? 

Bonus 100 points - What is the half-life of Lu-177m

Bonus 100 points - How long would Lu-177m need to be stored?

400

What is the chelator and ligand in Bexlutry?

Dota - Tate

400

What are the 2 amino acids needed for an infusion?

Bonus: Is there any concern about using the commercially available amino acids solutions?

L-lysine

L_arginine

Bonus: Possibly, because the commercially available solutions have more than these two amino acids, which could cause excess nausea. Consider specialty compounding as an option.

400

What dose modifications should be made, if any, for patients with baseline mild to moderate renal impairment?

What are other considerations?

Bonus: What about baseline severe renal impairment cases?

None

Patients may be at greater risk for renal toxicity due to increased radiation exposure, more frequent assessment of renal function in these patients is recommended.

Bonus: Baseline severe renal impairment cases has not been studied.

500

Daily Double

What is the Reduction in Risk of Progression or Death in Netter-1?

79%

Bonus: What is the Reduction in Risk of Progression or Death in Netter-2?

500

Describe the administration times for the entire Bexlutry administration (including anti-nausea meds and amino acid infusions). 

"30-30-30-3"

30 minutes - first 30 mins is anti-nausea meds

30 minutes - second 30 mins start amino acid infusion (before administering Bexlutry). 

30 minutes - third 30 mins (up to 40 mins) Bexlutry infusion, continue AA. 

3 hours - post Bexlutry infusion, continue AA infusion

500

How is Bexlutry eliminated and what is the amount of excretion within 5 hours and within 14 days of administration?

Bonus: Describe changes in the mean QTC interval and the hepatic metabolism of Bexlutry.

Renally 

Cumulative excretion of 44% within 5 hours and 99% within 14 days after administration of lutetium Lu 177 dotatate injection. 

Bonus: There were no large changes in the mean QTC interval, and it does not undergo hepatic metabolism